(Q36482518)

14 August 2017

1 reference

title

Advances in tuberculosis vaccine strategies (English)

1 reference

14 August 2017

0 references

1 reference

Yasir A W Skeiky

1

1 reference

14 August 2017

Jerald C Sadoff

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

Nature Reviews Microbiology

14 August 2017

published in

1 reference

14 August 2017

volume

4

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

469-476

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro1419

14 August 2017

exact match

0 references

cites work

Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Tuberculosis trends in eastern Europe and the former USSR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Evaluation of new anti-infective drugs for the treatment and prevention of infections caused by the Mycobacterium avium complex. Infectious Diseases Society of America and the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

TB vaccines at the turn of the century: insights into immunity to M. tuberculosis and modern approaches for prevention of an ancient disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Immunology of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Disseminated tuberculosis in interferon gamma gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Relationship between bacille Calmette-Guérin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Field trials of tuberculosis vaccines: how could we have done them better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Improved protection by recombinant BCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Comparative genomics of the mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Comparative genomics of BCG vaccines by whole-genome DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Detection of deleted genomic DNA using a semiautomated computational analysis of GeneChip data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

IS6110 mediates increased transcription of the phoP virulence gene in a multidrug-resistant clinical isolate responsible for tuberculosis outbreaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

An essential role for phoP in Mycobacterium tuberculosis virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Boosting vaccine for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

ExperimentalMycobacterium tuberculosisInfection of Cynomolgus Macaques Closely Resembles the Various Manifestations of HumanM. tuberculosisInfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRMICRO1419

21 January 2018

https://api.crossref.org/works/10.1038%2FNRMICRO1419

7 January 2021

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Tuberculosis in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Auxotrophic vaccines for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Lipoprotein antigens of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

The application of proteomics in defining the T cell antigens of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

Capacity of listeriolysin O, streptolysin O, and perfringolysin O to mediate growth of Bacillus subtilis within mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

7 January 2021

Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

7 January 2021

Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

7 January 2021

Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1419

7 January 2021

Identifiers

DOI

10.1038/NRMICRO1419

1 reference

14 August 2017

1 reference